Osiris Therapeutics (OSIR) Declares $0.20 Special Dividend; 1% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Osiris Therapeutics (OSIR) Names New CFO and CBO
September 17, 2015 8:02 AM EDTOsiris Therapeutics (NASDAQ: OSIR) announced the appointment of Gregory Law, to serve as Chief Financial Officer and Dwayne Montgomery, to serve as Chief Business Officer.
Mr. Law has been employed with Osiris since 2014 as the Vice President of Finance and Principal Accounting Officer. Mr. Law has more than 25 years of finance and accounting experience in a variety of industries, including biotechnology, telecommunications, energy, private equity and consulting. Prior to joining Osiris in 2014, Mr. Law spent over a decade providing consulting services to public and private companies in the areas of interim CFO and controllership,... More
